Longitudinal retinal imaging study of newly diagnosed relapsing-remitting multiple sclerosis in Scottish population: baseline and 12 months follow-up profile of FutureMS retinal imaging cohort

Yingdi Chen; Juan Larraz; Michael Wong; Patrick Kearns; Fraser Brown; Sarah-jane Martin; Peter Connick; Niall Macdougall; Christine Weaver; Baljean Dhillon; Siddharthan Chandran

doi:10.1136/bmjophth-2022-001024

Longitudinal retinal imaging study of newly diagnosed relapsing-remitting multiple sclerosis in Scottish population: baseline and 12 months follow-up profile of FutureMS retinal imaging cohort

Yingdi Chen, Juan Larraz, Michael Wong, Patrick Kearns, Fraser Brown, Sarah-jane Martin, Peter Connick, Niall Macdougall, Christine Weaver, Baljean Dhillon, Siddharthan Chandran

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e001024
Journal	BMJ Open Ophthalmology
Volume	7
Issue number	1
DOIs	https://doi.org/10.1136/bmjophth-2022-001024
Publication status	Published - 22 Jul 2022

Access to Document

10.1136/bmjophth-2022-001024

e001024.fullFinal published version, 507 KBLicence: Creative Commons: Attribution (CC-BY)

https://bmjophth.bmj.com/lookup/doi/10.1136/bmjophth-2022-001024

Cite this

Chen, Y., Larraz, J., Wong, M., Kearns, P., Brown, F., Martin, S., Connick, P., Macdougall, N., Weaver, C., Dhillon, B., & Chandran, S. (2022). Longitudinal retinal imaging study of newly diagnosed relapsing-remitting multiple sclerosis in Scottish population: baseline and 12 months follow-up profile of FutureMS retinal imaging cohort. BMJ Open Ophthalmology, 7(1), e001024. https://doi.org/10.1136/bmjophth-2022-001024

@article{d51b146894f7446cb86783107b1ae38e,

title = "Longitudinal retinal imaging study of newly diagnosed relapsing-remitting multiple sclerosis in Scottish population: baseline and 12 months follow-up profile of FutureMS retinal imaging cohort",

author = "Yingdi Chen and Juan Larraz and Michael Wong and Patrick Kearns and Fraser Brown and Sarah-jane Martin and Peter Connick and Niall Macdougall and Christine Weaver and Baljean Dhillon and Siddharthan Chandran",

note = "Funding Information: FutureMS has been funded by Precision Medicine Scotland Innovation Centre (PMS-IC), the Anne Rowling Regenerative Neurology Clinic, and Biogen Idec. Insurance provided by the cosponsors: NHS Lothian and the University of Edinburgh. This work is supported by the UK Dementia Research Institute which receives its funding from UK DRI, funded by the UK Medical Research Council, Alzheimer{\textquoteright}s Society and Alzheimer{\textquoteright}s Research UK. Funding Information: FutureMS has been funded by Precision Medicine Scotland Innovation Centre (PMS_IC), the Anne Rowling Regenerative Neurology Clinic, and Biogen Idec. Insurance provided by the cosponsors: NHS Lothian and the University of Edinburgh. This work is supported by the UK Dementia Research Institute which receives its funding from UK DRI, funded by the UK Medical Research Council, Alzheimer{\textquoteright}s Society and Alzheimer{\textquoteright}s Research UK. Funding Information: With thank to FutureMS, hosted by Precision Medicine Scotland Innovation Centre (PMS-IC) and funded by a grant from the Scottish Funding Council to PMS-IC and Biogen Idec Insurance(combined funding under reference Exemplar SMS_IC010). We would like to thanks other non-author contributors of the FutureMS consortium as follows: Rozanna Meijboom, Elizabeth N York, Dominic Job, Chris Batchelor, Tracy Brunton, Shuna Colville, Annette Cooper, Rachel Dakin, Liz Elliott, Peter Foley, David Hunt, Aidan Hutchinson, Charlotte Jardine, Lucy Kesseler, Michaela Kleynhans, Jen MacFarlane, Bev MacLennan, Mary Monaghan, Scott Semple, Adam Scotson, Amy Stenson and Rosie Woodward.With special thanks to all FutureMS participants who have made this study possible. Additional funding for authors came from the NHS Lothian Research and Development Office (MJT),Chief Scientist Office-SPRINT MND/MS programme (ENY) and the Row Fogo Charitable Trust (Grant No. BROD.FID3668413; MVH) Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..All right reserved.",

year = "2022",

month = jul,

day = "22",

doi = "10.1136/bmjophth-2022-001024",

language = "English",

volume = "7",

pages = "e001024",

journal = "BMJ Open Ophthalmology",

issn = "2397-3269",

publisher = "BMJ Publishing Group",

number = "1",

}

Chen, Y, Larraz, J, Wong, M, Kearns, P, Brown, F, Martin, S, Connick, P, Macdougall, N, Weaver, C, Dhillon, B & Chandran, S 2022, 'Longitudinal retinal imaging study of newly diagnosed relapsing-remitting multiple sclerosis in Scottish population: baseline and 12 months follow-up profile of FutureMS retinal imaging cohort', BMJ Open Ophthalmology, vol. 7, no. 1, pp. e001024. https://doi.org/10.1136/bmjophth-2022-001024

Longitudinal retinal imaging study of newly diagnosed relapsing-remitting multiple sclerosis in Scottish population: baseline and 12 months follow-up profile of FutureMS retinal imaging cohort. / Chen, Yingdi; Larraz, Juan; Wong, Michael et al.
In: BMJ Open Ophthalmology, Vol. 7, No. 1, 22.07.2022, p. e001024.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Longitudinal retinal imaging study of newly diagnosed relapsing-remitting multiple sclerosis in Scottish population: baseline and 12 months follow-up profile of FutureMS retinal imaging cohort

AU - Chen, Yingdi

AU - Larraz, Juan

AU - Wong, Michael

AU - Kearns, Patrick

AU - Brown, Fraser

AU - Martin, Sarah-jane

AU - Connick, Peter

AU - Macdougall, Niall

AU - Weaver, Christine

AU - Dhillon, Baljean

AU - Chandran, Siddharthan

N1 - Funding Information: FutureMS has been funded by Precision Medicine Scotland Innovation Centre (PMS-IC), the Anne Rowling Regenerative Neurology Clinic, and Biogen Idec. Insurance provided by the cosponsors: NHS Lothian and the University of Edinburgh. This work is supported by the UK Dementia Research Institute which receives its funding from UK DRI, funded by the UK Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK. Funding Information: FutureMS has been funded by Precision Medicine Scotland Innovation Centre (PMS_IC), the Anne Rowling Regenerative Neurology Clinic, and Biogen Idec. Insurance provided by the cosponsors: NHS Lothian and the University of Edinburgh. This work is supported by the UK Dementia Research Institute which receives its funding from UK DRI, funded by the UK Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK. Funding Information: With thank to FutureMS, hosted by Precision Medicine Scotland Innovation Centre (PMS-IC) and funded by a grant from the Scottish Funding Council to PMS-IC and Biogen Idec Insurance(combined funding under reference Exemplar SMS_IC010). We would like to thanks other non-author contributors of the FutureMS consortium as follows: Rozanna Meijboom, Elizabeth N York, Dominic Job, Chris Batchelor, Tracy Brunton, Shuna Colville, Annette Cooper, Rachel Dakin, Liz Elliott, Peter Foley, David Hunt, Aidan Hutchinson, Charlotte Jardine, Lucy Kesseler, Michaela Kleynhans, Jen MacFarlane, Bev MacLennan, Mary Monaghan, Scott Semple, Adam Scotson, Amy Stenson and Rosie Woodward.With special thanks to all FutureMS participants who have made this study possible. Additional funding for authors came from the NHS Lothian Research and Development Office (MJT),Chief Scientist Office-SPRINT MND/MS programme (ENY) and the Row Fogo Charitable Trust (Grant No. BROD.FID3668413; MVH) Publisher Copyright: © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..All right reserved.

PY - 2022/7/22

Y1 - 2022/7/22

U2 - 10.1136/bmjophth-2022-001024

DO - 10.1136/bmjophth-2022-001024

M3 - Article

SN - 2397-3269

VL - 7

SP - e001024

JO - BMJ Open Ophthalmology

JF - BMJ Open Ophthalmology

IS - 1

ER -